The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 16th 2025
An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Brain imaging study uncovers neurophysiology of drunken behavior
April 30th 2008New brain imaging research shows that social drinkers experience decreased sensitivity in brain regions involved in detecting threats and increased activity in regions involved in reward after consuming alcohol. The first human brain imaging study of alcohol’s effect on the response of neuronal circuits to threatening stimuli appears in the April 30 issue of The Journal of Neuroscience.
Brain and spine imaging benefit from increased field strength
April 30th 2008Neuroimaging with MRI at 3T is superior for nearly every application in the brain and spine, and it is certainly inferior for none. The technique has unique strengths for performing vascular work and functional brain imaging, but there is nothing that a 3T MR scanner can't do better than a 1.5T machine.
Report from ARRS: Breast MRI CAD zeroes in on malignancies
April 17th 2008Computer-aided detection schemes for breast MR imaging have shown plenty of promise, but they always fall short of full automation and lesion characterization. Two recent studies, however, suggest CAD for breast MRI may be closing in on true cancer detection.
NSF lawsuit discovery process may expose lax contrast documentation
April 16th 2008A casual attitude toward keeping track of gadolinium-enhanced studies may come back to haunt radiology departments that have become involved in several federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents.
Scientific abstracts indicate growing prestige of ARRS annual meeting
April 15th 2008What’s happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.
Florida radiologist agrees to pay $7 million to resolve kickback claims
April 15th 2008Dr. Fred L. Steinberg and his imaging centers and related entities in Palm Beach County near Miami will pay $7 million to settle alleged violations of federal Stark self-referral law and anti-kickback statutes. He was also charged with billing fraud.
Report from ARRS: Study establishes infection as NSF risk factor
April 14th 2008New evidence has surfaced pinpointing specific potential causes of nephrogenic systemic fibrosis. Findings sustain its relationship to some gadolinium-based contrast media, but they also suggest that infection, certain patient demographics, and even some drugs could be strongly associated with the condition.
Proton MRS links fibromyalgia pain to changes in brain molecule
April 10th 2008Widespread muscle and tissue pain, tenderness, and fatigue are well-documented symptoms of fibromyalgia, a chronic condition that affects up to an estimated 6% of the U.S. population. The underlying pathology of the pain disease is unknown. A new study featuring proton MR spectroscopy, however, has found a key linkage between the pain and a specific brain molecule.
New recommendations target NSF risk
April 2nd 2008Nephrogenic systemic fibrosis has received widespread attention, but official protocols on how to avoid the life-threatening skin condition are quite sparse: Only one section in the American College of Radiology’s 2007 white paper on safe MR practices is devoted to the condition.
Imaging modalities shed light on intracranial cysts
Any fluid-filled cavity or sac that is lined by an epithelium is a cyst, and intracranial cystic lesions are a common finding on CT and MR imaging of the brain.1,2 These lesions contain either cerebrospinal fluid, fluid that is similar to CSF, mucus, or proteinaceous fluid. They are lined by epithelial cells, inflammatory cells, or glial cells. The attenuation characteristics of the cyst on CT and MRI and the contrast enhancement patterns depend on the cyst's contents and the composition of the wall.
Report from SIR: Cryotherapy proves long-term effectiveness in primary renal cancer
March 26th 2008Results from two clinical trials demonstrate that cryoablation of renal cell carcinomas is effective at least a year after treatment in nearly all patients with lesions 4 cm or smaller. The studies suggest that cryotherapy could serve as an alternative to surgery.
Panel orders centralized pretrial proceedings in NSF cases
March 20th 2008The discovery process for more than 60 federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents will be consolidated at a single district court in Ohio, according to a U.S. judicial panel. Centralization will accelerate the discovery process and give plaintiffs access to a wider pool of pretrial information.
MRI unveils hidden cardiac disease in patients with systemic sclerosis
March 13th 2008Cardiac MR imaging with delayed gadolinium enhancement can detect silent myocardial fibrosis and other cardiac abnormalities in patients with systemic sclerosis, German researchers told attendees of a cardiac session in Vienna.
Whole-body cancer staging requires frequent follow-up in some patients
March 12th 2008Whole-body MRI is more sensitive but less specific than FDG-PET/CT for cancer detection, according to researchers from China and Europe. Findings suggest a complementary rather than exclusive role in oncologic imaging for both modalities and validate recent studies suggesting close follow-up since either test can miss metastases.